JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M308434200 on December 12, 2003

J. Biol. Chem., Vol. 279, Issue 11, 10710-10719, March 12, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
279/11/10710    most recent
M308434200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sawada, H.
Right arrow Articles by Shimohama, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sawada, H.
Right arrow Articles by Shimohama, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Proteasome Mediates Dopaminergic Neuronal Degeneration, and Its Inhibition Causes {alpha}-Synuclein Inclusions*

Hideyuki Sawada{ddagger}, Ryuichi Kohno{ddagger}, Takeshi Kihara{ddagger}, Yasuhiko Izumi§, Noriko Sakka§, Masakazu Ibi§, Miki Nakanishi§, Tomoki Nakamizo{ddagger}, Kentarou Yamakawa{ddagger}, Hiroshi Shibasaki{ddagger}, Noriyuki Yamamoto§, Akinori Akaike§, Masatoshi Inden¶, Yoshihisa Kitamura¶, Takashi Taniguchi¶, and Shun Shimohama{ddagger}||

From the {ddagger}Department of Neurology, Graduate School of Medicine, 54 Shogoin-Kawaharacho, Sakyoku, Kyoto 606-8507, Japan, §Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Shimoadachicho, Sakyoku, Kyoto 606-8501, Japan, and Department of Neurobiology, Kyoto Pharmaceutical University, Kyoto, Misasagi, Yamashinaku, Kyoto 607-8412, Japan

Parkinson's disease is characterized by dopaminergic neuronal death and the presence of Lewy bodies. {alpha}-Synuclein is a major component of Lewy bodies, but the process of its accumulation and its relationship to dopaminergic neuronal death has not been resolved. Although the pathogenesis has not been clarified, mitochondrial complex I is suppressed, and caspase-3 is activated in the affected midbrain. Here we report that a combination of 1-methyl-4-phenylpyridinium ion (MPP+) or rotenone and proteasome inhibition causes the appearance of {alpha}-synuclein-positive inclusion bodies. Unexpectedly, however, proteasome inhibition blocked MPP+- or rotenone-induced dopaminergic neuronal death. MPP+ elevated proteasome activity, dephosphorylated mitogen-activating protein kinase (MAPK), and activated caspase-3. Proteasome inhibition reversed the MAPK dephosphorylation and blocked caspase-3 activation; the neuroprotection was blocked by a p42 and p44 MAPK kinase inhibitor. Thus, the proteasome plays an important role in both inclusion body formation and dopaminergic neuronal death but these processes form opposite sides on the proteasome regulation in this model.


Received for publication, August 1, 2003 , and in revised form, December 10, 2003.

* This work was supported by Grant-in-aid for Scientific Research (to H. S.) from Japan Society for the Promotion of Science 14570591 and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains Supplemental Figs. 1-4.

|| To whom correspondence should be addressed. Tel.: 81-75-751-3771; Fax: 81-75-751-3265; E-mail: i53367{at}sakura.kudpc.kyoto-u.ac.jp.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
K. Assayag, E. Yakunin, V. Loeb, D. J. Selkoe, and R. Sharon
Polyunsaturated Fatty Acids Induce {alpha}-Synuclein-Related Pathogenic Changes in Neuronal Cells
Am. J. Pathol., December 1, 2007; 171(6): 2000 - 2011.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. L. Conway-Campbell, M. A. McKenna, C. C. Wiles, H. C. Atkinson, E. R. de Kloet, and S. L. Lightman
Proteasome-Dependent Down-Regulation of Activated Nuclear Hippocampal Glucocorticoid Receptors Determines Dynamic Responses to Corticosterone
Endocrinology, November 1, 2007; 148(11): 5470 - 5477.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Yamamoto, H. Sawada, Y. Izumi, T. Kume, H. Katsuki, S. Shimohama, and A. Akaike
Proteasome Inhibition Induces Glutathione Synthesis and Protects Cells from Oxidative Stress: RELEVANCE TO PARKINSON DISEASE
J. Biol. Chem., February 16, 2007; 282(7): 4364 - 4372.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J.-h. Zhu, C. Horbinski, F. Guo, S. Watkins, Y. Uchiyama, and C. T. Chu
Regulation of Autophagy by Extracellular Signal-Regulated Protein Kinases During 1-Methyl-4-Phenylpyridinium-Induced Cell Death
Am. J. Pathol., January 1, 2007; 170(1): 75 - 86.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. da Costa, J. Dunys, F. Brau, S. Wilk, R. Cappai, and F. Checler
6-Hydroxydopamine but Not 1-Methyl-4-phenylpyridinium Abolishes {alpha}-Synuclein Anti-apoptotic Phenotype by Inhibiting Its Proteasomal Degradation and by Promoting Its Aggregation
J. Biol. Chem., April 7, 2006; 281(14): 9824 - 9831.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Chen, J. Thorpe, and J. N. Keller
{alpha}-Synuclein Alters Proteasome Function, Protein Synthesis, and Stationary Phase Viability
J. Biol. Chem., August 26, 2005; 280(34): 30009 - 30017.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Snyder, K. Mensah, C. Hsu, M. Hashimoto, I. G. Surgucheva, B. Festoff, A. Surguchov, E. Masliah, A. Matouschek, and B. Wolozin
{beta}-Synuclein Reduces Proteasomal Inhibition by {alpha}-Synuclein but Not {gamma}-Synuclein
J. Biol. Chem., March 4, 2005; 280(9): 7562 - 7569.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Martin-Clemente, B. Alvarez-Castelao, I. Mayo, A. B. Sierra, V. Diaz, M. Milan, I. Farinas, T. Gomez-Isla, I. Ferrer, and J. G. Castano
{alpha}-Synuclein Expression Levels Do Not Significantly Affect Proteasome Function and Expression in Mice and Stably Transfected PC12 Cell Lines
J. Biol. Chem., December 17, 2004; 279(51): 52984 - 52990.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.